Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by Justfishin73on Mar 30, 2017 2:55pm
125 Views
Post# 26053961

RE:Investor's Crossroads

RE:Investor's Crossroads
HonestAbe wrote: From my observations the stock chart was poised for a technical breakout just prior to Q3 quarterly financials, but it did not happen (primarily due to the interpretation of the quarterly results), and then negative sentiment created by the Mettrum lawsuit.

As it stands the valuation of this company is divided into main camps.  One is the group that believes WEED is insanely overvalued and bleeding red ink with negative EBITDA and somewhat concerned by the negligible Q on Q revenue growth compounded by highly inflated inventory level.  The other group believes WEED's corporate strategy of obtaining market share by aggressive growth and rapid expansion at the expense of near term cash flow and lack of profitability is the correct strategy, and they can see that last quarter's revenue was constrained by massive inventory that was not ready for sale yet.

What this means is the stock is in the penalty box and likely to consolidate and even under perform its peers until the true nature of this situation is revealed.  And the only truth at the earliest is when Q4 and next fiscal year's Q1 gets released in June and August later this year.  Too many negative print about biological accounting and net operational losses for company to get further traction until next couple of quarterlies are released IMHO.


Excellent post
Bullboard Posts